Virtual monoenergetic images from spectral detector CT as a surrogate for conventional CT images: Unaltered attenuation characteristics with reduced image noise

Objective: This study aimed to identify the energy level of virtual monoenergetic images (VMI) that closest represents conventional images (CI) in order to demonstrate that these images provide improved image quality in terms of noise and Signal-to-noise ratio (SD/SNR) while attenuation values (HU) remain unaltered as compared to CI. Methods: 60 and 30 patients with contrast-enhanced (CE) and non-enhanced (NCE) spectral detector CT (SDCT) of the abdomen were included in this retrospective, IRB-approved study. CI and VMI of 66-74 keV as well as quantitative iodine maps were reconstructed (Q-IodMap). Two regions of interest were placed in each: pulmonary trunk, abdominal aorta, portal vein, liver, pancreas, renal cortex left/right, psoas muscle, (filled) bladder and subcutaneous fat. For each reconstruction, HU and SD were averaged. Delta HU and SNR (SNR = HU/SD) were calculated. Q-IodMap were considered as confounder for Delta HU. In addition, two radiologists compared VMI of 72 keV and CI in a forced-choice approach regarding image quality. Results: In NCE studies, no significant differences for any region was found. In CE studies, VMI72keV images showed lowest Delta HU (HUliver CI/VMI72keV: 104 +/- 18/103 +/- 17, p >= 0.05). Iodine containing voxels as indicated by Q-IodMap resulted in an over- and underestimation of attenuation in lower and higher VMI energies, respectively. Image noise was lower in VMI images (e.g. muscle: CI/VMI72keV: 15.3 +/- 3.3/12.3 +/- 2.9 HU, p <= 0.05). Hence, SNR was significantly higher in VMI72keV compared to CI (e.g. liver 3.8 +/- 0.6 vs 3.0 +/- 0.8, p <= 0.05). In visual analysis, VMI72keV were preferred over CI at all times. Conclusions: VMI72keV show improved SD/SNR characteristics while the attenuation remains unaltered as compared to CI

Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients The ENDORSE Global Survey

Limited data are available regarding the risk for venous thromboembolism (VIE) and VIE prophylaxis use in hospitalised medically ill patients. We analysed data from the global ENDORSE survey to evaluate VTE risk and prophylaxis use in this population according to diagnosis, baseline characteristics, and country. Data on patient characteristics, VIE risk, and prophylaxis use were abstracted from hospital charts. VTE risk and prophylaxis use were evaluated according to the 2004 American College of Chest Physicians (ACCP) guidelines. Multivariable analysis was performed to identify factors associated with use of ACCP-recommended prophylaxis. Data were evaluated for 37,356 hospitalised medical patients across 32 countries. VIE risk varied according to medical diagnosis, from 31.2% of patients with gastrointestinal/hepatobiliary diseases to 100% of patients with acute heart failure, active noninfectious respiratory disease, or pulmonary infection (global rate, 41.5%). Among those at risk for VTE, ACCP-recommended prophylaxis was used in 24.4% haemorrhagic stroke patients and 40-45% of cardiopulmonary disease patients (global rate, 39.5%). Large differences in prophylaxis use were observed among countries. Markers of disease severity, including central venous catheters, mechanical ventilation, and admission to intensive care units, were strongly associated with use of ACCP-recommended prophylaxis. In conclusion, VIE risk varies according to medical diagnosis. Less than 40% of at-risk hospitalised medical patients receive ACCP-recommended prophylaxis. Prophylaxis use appears to be associated with disease severity rather than medical diagnosis. These data support the necessity to improve implementation of available guidelines for evaluating VIE risk and providing prophylaxis to hospitalised medical patients

Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting (ENDORSE Survey) Findings in Surgical Patients

Objective: To evaluate venous thromboembolism (VTE) risk in patients who underwent a major operation, including the use of, and factors influencing, American College of Chest Physicians-recommended types of VTE prophylaxis